BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan NU, Ni J, Ju X, Miao T, Chen H, Han L. Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment. Acta Pharm Sin B 2021;11:1341-54. [PMID: 34094838 DOI: 10.1016/j.apsb.2020.10.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Jia W, Liu R, Wang Y, Hu C, Yu W, Zhou Y, Wang L, Zhang M, Gao H, Gao X. Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancer. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.03.010] [Reference Citation Analysis]
2 Yang T, Hu Y, Miao J, Chen J, Liu J, Cheng Y, Gao X. A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.009] [Reference Citation Analysis]
3 Hu K, Zhou D, Rao L, Wang P, Xiang C, Chen F. A Multifunctional AIE Nanoprobe as a Drug Delivery Bioimaging and Cancer Treatment System. Front Bioeng Biotechnol 2021;9:766470. [PMID: 34820365 DOI: 10.3389/fbioe.2021.766470] [Reference Citation Analysis]
4 Liu R, Luo C, Pang Z, Zhang J, Ruan S, Wu M, Wang L, Sun T, Li N, Han L, Shi J, Huang Y, Guo W, Peng S, Zhou W, Gao H. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.05.032] [Reference Citation Analysis]
5 Ju X, Chen H, Miao T, Ni J, Han L. Prodrug Delivery Using Dual-Targeting Nanoparticles To Treat Breast Cancer Brain Metastases. Mol Pharm 2021;18:2694-702. [PMID: 34109794 DOI: 10.1021/acs.molpharmaceut.1c00224] [Reference Citation Analysis]
6 Mao X, Wang X, Jin M, Li Q, Jia J, Li M, Zhou H, Liu Z, Jin W, Zhao Y, Luo Z. Critical involvement of lysyl oxidase in seizure-induced neuronal damage through ERK-Alox5-dependent ferroptosis and its therapeutic implications. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.04.017] [Reference Citation Analysis]
7 Chen H, Zhou M, Zeng Y, Miao T, Luo H, Tong Y, Zhao M, Mu R, Gu J, Yang S, Han L. Biomimetic Lipopolysaccharide-Free Bacterial Outer Membrane-Functionalized Nanoparticles for Brain-Targeted Drug Delivery. Adv Sci (Weinh) 2022;:e2105854. [PMID: 35355446 DOI: 10.1002/advs.202105854] [Reference Citation Analysis]
8 Liu D, Huang J, Gao S, Jin H, He J. A temporo-spatial pharmacometabolomics method to characterize pharmacokinetics and pharmacodynamics in the brain microregions by using ambient mass spectrometry imaging. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.03.018] [Reference Citation Analysis]
9 Habib S, Singh M. Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review. Polymers 2022;14:712. [DOI: 10.3390/polym14040712] [Reference Citation Analysis]
10 Han L. Brain metastases: Nanomedicine-boosted diagnosis and treatment. Medicine in Drug Discovery 2022;13:100111. [DOI: 10.1016/j.medidd.2021.100111] [Reference Citation Analysis]
11 Han L. Modulation of the Blood-Brain Barrier for Drug Delivery to Brain. Pharmaceutics 2021;13:2024. [PMID: 34959306 DOI: 10.3390/pharmaceutics13122024] [Reference Citation Analysis]